Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
obesity drugs
Pharma
Generic versions of Novo's semaglutide launch today in India
With patents for Novo Nordisk’s semaglutide expiring in India, more than 40 drugmakers will begin launching their cheaper copycats in the country.
Kevin Dunleavy
Mar 20, 2026 11:27am
Rhythm's Imcivree bags FDA nod for brain-damage related obesity
Mar 20, 2026 11:05am
Novo scores FDA nod for Wegovy HD, plans April launch
Mar 19, 2026 2:11pm
Lilly's shares have dropped by 7% since HSBC downgrade
Mar 18, 2026 3:36pm
Lilly, Pfizer-Sciwind, Astellas—Fierce Pharma Asia
Mar 13, 2026 8:05am
Fierce Biotech
How GLP-1s help the heart relax: study
Mar 2, 2026 7:01pm
